Literature DB >> 33541543

Acute Kidney Injury Following In-Patient Lower Extremity Vascular Intervention: From the National Cardiovascular Data Registry.

David M Safley1, Adam C Salisbury2, Thomas T Tsai3, Eric A Secemsky4, Kevin F Kennedy2, R Kevin Rogers5, Faisal Latif6, Nicolas W Shammas7, Lawrence Garcia8, Matthew A Cavender9, Kenneth Rosenfield10, Anand Prasad11, John A Spertus2.   

Abstract

OBJECTIVES: The authors analyzed data from the NCDR (National Cardiovascular Data Registry) PVI Registry and defined acute kidney injury (AKI) as increased creatinine of ≥0.3 mg/dl or 50%, or a new requirement for dialysis after PVI.
BACKGROUND: AKI is an important and potentially modifiable complication of peripheral vascular intervention (PVI). The incidence, predictors, and outcomes of AKI after PVI are incompletely characterized.
METHODS: A hierarchical logistic regression risk model using pre-procedural characteristics associated with AKI was developed, followed by bootstrap validation. The model was validated with data submitted after model creation. An integer scoring system was developed to predict AKI after PVI.
RESULTS: Among 10,006 procedures, the average age of patients was 69 years, 58% were male, and 52% had diabetes. AKI occurred in 737 (7.4%) and was associated with increased in-hospital mortality (7.1% vs. 0.7%). Reduced glomerular filtration rate, hypertension, diabetes, prior heart failure, critical or acute limb ischemia, and pre-procedural hemoglobin were independently associated with AKI. The model to predict AKI showed good discrimination (optimism corrected c-statistic = 0.68) and calibration (corrected slope = 0.97, intercept of -0.07). The integer point system could be incorporated into a useful clinical tool because it discriminates risk for AKI with scores ≤4 and ≥12 corresponding to the lower and upper 20% of risk, respectively.
CONCLUSIONS: AKI is not rare after PVI and is associated with in-hospital mortality. The NCDR PVI AKI risk model, including the integer scoring system, may prospectively estimate AKI risk and aid in deployment of strategies designed to reduce risk of AKI after PVI.
Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute kidney injury; peripheral intervention; risk model

Year:  2021        PMID: 33541543      PMCID: PMC8076888          DOI: 10.1016/j.jcin.2020.10.028

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  38 in total

1.  Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial.

Authors:  Somjot S Brar; Vicken Aharonian; Prakash Mansukhani; Naing Moore; Albert Y-J Shen; Michael Jorgensen; Aman Dua; Lindsay Short; Kevin Kane
Journal:  Lancet       Date:  2014-05-24       Impact factor: 79.321

2.  The National Cardiovascular Data Registry (NCDR) Data Quality Brief: the NCDR Data Quality Program in 2012.

Authors:  John C Messenger; Kalon K L Ho; Christopher H Young; Lara E Slattery; Jasmine C Draoui; Jeptha P Curtis; Gregory J Dehmer; Frederick L Grover; Michael J Mirro; Matthew R Reynolds; Ivan C Rokos; John A Spertus; Tracy Y Wang; Stuart A Winston; John S Rumsfeld; Frederick A Masoudi
Journal:  J Am Coll Cardiol       Date:  2012-09-19       Impact factor: 24.094

3.  Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography.

Authors:  Roxana Mehran; Michela Faggioni; Jaya Chandrasekhar; Dominick J Angiolillo; Barry Bertolet; Robert Lee Jobe; Bassam Al-Joundi; Somjot Brar; George Dangas; Wayne Batchelor; Anand Prasad; Hitinder S Gurm; James Tumlin; Gregg W Stone
Journal:  JACC Cardiovasc Interv       Date:  2018-08-27       Impact factor: 11.195

4.  Contrast-induced nephropathy and peripheral intervention: Who's keeping track?

Authors:  Michael J Lipinski; Lowell F Satler
Journal:  Catheter Cardiovasc Interv       Date:  2016-08       Impact factor: 2.692

5.  Risk factors and safe contrast volume thresholds for postcontrast acute kidney injury after peripheral vascular interventions.

Authors:  Shin-Rong Lee; Haoran Zhuo; Yawei Zhang; Neera Dahl; Alan Dardik; Cassius Iyad Ochoa Chaar
Journal:  J Vasc Surg       Date:  2019-12-13       Impact factor: 4.268

6.  Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.

Authors:  Yaling Han; Guoying Zhu; Lixian Han; Fengxia Hou; Weijian Huang; Huiliang Liu; Jihong Gan; Tiemin Jiang; Xiaoyan Li; Wei Wang; Shifang Ding; Shaobin Jia; Weifeng Shen; Dongmei Wang; Ling Sun; Jian Qiu; Xiaozeng Wang; Yi Li; Jie Deng; Jing Li; Kai Xu; Bo Xu; Roxana Mehran; Yong Huo
Journal:  J Am Coll Cardiol       Date:  2013-09-26       Impact factor: 24.094

7.  Contrast-induced nephropathy in patients undergoing endovascular peripheral vascular intervention: Incidence, risk factors, and outcomes as observed in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.

Authors:  P Michael Grossman; Syed S Ali; Herbert D Aronow; Michael Boros; Timothy J Nypaver; Theodore L Schreiber; Yeo Jung Park; Peter K Henke; Hitinder S Gurm
Journal:  J Interv Cardiol       Date:  2017-04-03       Impact factor: 2.279

8.  Impact of a novel contrast reduction system on contrast savings in coronary angiography - The DyeVert randomised controlled trial.

Authors:  Steffen Desch; Georg Fuernau; Janine Pöss; Roza Meyer-Saraei; Mohammed Saad; Ingo Eitel; Holger Thiele; Suzanne de Waha
Journal:  Int J Cardiol       Date:  2018-01-02       Impact factor: 4.164

9.  National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors:  Andrew S Levey; Josef Coresh; Ethan Balk; Annamaria T Kausz; Adeera Levin; Michael W Steffes; Ronald J Hogg; Ronald D Perrone; Joseph Lau; Garabed Eknoyan
Journal:  Ann Intern Med       Date:  2003-07-15       Impact factor: 25.391

Review 10.  Acute kidney injury following peripheral angiography and endovascular therapy: A systematic review of the literature.

Authors:  Anand Prasad; Carolina Ortiz-Lopez; Aazib Khan; Daniel Levin; David M Kaye
Journal:  Catheter Cardiovasc Interv       Date:  2016-03-04       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.